Financing type:  underwritten prospectus offering

Gross proceeds:  $28,773,000

Offering:  39,962,500 listed shares

Offering price:  72 cents per listed share

Overallotment option:  The underwriters may purchase a maximum of 5,212,500 listed shares for overallotment purposes. As of Oct. 10, 2025, such option has been exercised in full and therefore 5,212,500 listed shares have been issued thereunder. All information presented herein includes such exercise.

Commissions in securities:  not applicable (commission in cash only)

Disclosure:  Refer to the prospectus dated Oct. 2, 2025, and the company's news releases dated Sept. 15, 2025, Oct. 2, 2025, and Oct. 7, 2025.